source name	characteristics[organism]	characteristics[organism part]	characteristics[strain/breed]	characteristics[developmental stage]	characteristics[disease]	characteristics[sex]	characteristics[ancestry category]	characteristics[age]	characteristics[cultured cell]	characteristics[cell line]	characteristics[cell type]	characteristics[individual]	characteristics[biological replicate]	material type	assay name	technology type	comment[file]	comment[label]	comment[fractionation method]	comment[technical replicate]	comment[fraction identifier]	comment[ms2 mass analyzer]	comment[instrument]	comment[separation]	comment[file uri]	comment[dissociation method]	comment[collision energy]	comment[cleavage agent details]	comment[cleavage agent details]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[data file]
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 1	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc1 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 2	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 3	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 4	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 5	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 6	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 7	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 8	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 9	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 10	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc2 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 11	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 12	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 13	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 14	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 15	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 16	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc3 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 17	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc4 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 18	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc5 (2).raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 19	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 20	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 21	proteomic profiling by mass spectrometry	20161006_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 22	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 23	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 24	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 25	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 26	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 27	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 28	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 29	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 30	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 31	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 32	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 33	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 34	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 35	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 36	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 37	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 38	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 39	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 40	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 41	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 42	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 43	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 44	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 80	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 45	proteomic profiling by mass spectrometry	20161006_QEp2_PhGe_SA_LC12-14_Top6Top14Depl_SDBC_24Frac_Frac9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 46	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 47	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 48	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 49	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 50	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 51	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 52	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 53	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 54	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 55	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 56	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 57	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 58	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 59	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 60	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 61	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 62	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 63	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 64	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 65	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 66	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 67	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 68	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 81	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 69	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads__24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 70	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 71	proteomic profiling by mass spectrometry	20161008_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 72	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 73	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 74	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 75	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 76	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 77	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 78	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 79	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 80	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 81	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 82	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 83	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 84	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 85	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 86	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 87	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 88	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 89	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 90	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 91	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 92	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 93	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 94	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 82	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 95	proteomic profiling by mass spectrometry	20161013_QEp2_PhGe_SA_LC12-14_Top14Top6Depl_SDB_24Frc_Frc9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 79	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 96	proteomic profiling by mass spectrometry	20161017_QEp1_PhGe_SA_LC12-14_Top14Top6Depl_Beads_24Frc_Frc7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 97	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 98	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F10_170503153643.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 99	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 100	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 101	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 102	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 103	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 104	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 105	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 106	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 107	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 108	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 109	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 110	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 111	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 112	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 113	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 114	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 115	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 116	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 117	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 118	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 119	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 83	homo sapiens	plasma	not available	not available	cirrhosis of liver	not available	not available	not available	not available	not available	not available	not available	1	nan	run 120	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Cirrhosis_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 121	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F1_170427224508.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 122	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 123	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 124	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 125	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 126	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 127	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 128	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 129	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 130	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 131	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 132	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F2_170427235251.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 133	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 134	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 135	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 136	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 137	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 138	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F3_170428010030.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 139	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F4_170428020817.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 140	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 141	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 142	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 143	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 84	homo sapiens	plasma	not available	not available	normal	not available	not available	not available	not available	not available	not available	not available	1	nan	run 144	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_Healthy_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 145	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F1.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 146	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F10.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	10	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 147	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F11.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	11	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 148	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F12.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	12	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 149	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F13.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	13	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 150	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F14.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	14	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 151	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F15.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	15	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 152	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F16.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	16	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 153	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F17.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	17	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 154	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F18.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	18	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 155	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F19.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	19	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 156	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F2.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	2	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 157	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F20.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	20	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 158	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F21.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	21	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 159	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F22.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	22	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 160	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F23.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	23	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 161	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F24.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	24	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 162	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F3.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	3	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 163	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F4.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	4	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 164	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F5.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	5	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 165	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F6.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	6	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 166	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F7.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	7	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 167	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F8.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	8	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 85	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	not available	not available	not available	not available	not available	not available	not available	1	nan	run 168	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Human_NAFLD_F9.raw	AC=MS:1002038;NT=label free sample	AC=PRIDE:0000564;NT=High-pH reversed-phase chromatography (hpHRP)	1	9	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	27 eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	1	nan	run 169	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_1_A1_170407145349.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	1	nan	run 170	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	1	nan	run 171	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	1	nan	run 172	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	1	nan	run 173	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_13_B1_170410214309.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	1	nan	run 174	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_14_B2_170410172255.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	1	nan	run 175	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	1	nan	run 176	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	1	nan	run 177	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_17_B5_170410193253.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	1	nan	run 178	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_18_B6_170411020408.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	1	nan	run 179	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_19_B7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	1	nan	run 180	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_2_A2_170411115256.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	1	nan	run 181	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	1	nan	run 182	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	1	nan	run 183	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	1	nan	run 184	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_23_B11_170411083623.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	1	nan	run 185	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_24_B12_170411005852.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	1	nan	run 186	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	1	nan	run 187	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_26_C2_170411182553.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	1	nan	run 188	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	1	nan	run 189	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	1	nan	run 190	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_3_A3_170410151303.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	1	nan	run 191	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	1	nan	run 192	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_31_C6_170410140811.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	1	nan	run 193	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_32_C7_170410130315.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	1	nan	run 194	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_33_C8_170410235334.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	1	nan	run 195	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	1	nan	run 196	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	1	nan	run 197	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	1	nan	run 198	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_37_C12_170411193130.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	1	nan	run 199	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	1	nan	run 200	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_39_D2_170411041450.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	1	nan	run 201	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	1	nan	run 202	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	nan	not available	62	not available	not available	not available	41	1	nan	run 203	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	1	nan	run 204	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	1	nan	run 205	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	1	nan	run 206	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	1	nan	run 207	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	1	nan	run 208	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_46_D9_170407155901.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	1	nan	run 209	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	1	nan	run 210	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	1	nan	run 211	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_49_D12_170411030928.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	1	nan	run 212	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	1	nan	run 213	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_50_E1_170410203801.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	1	nan	run 214	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	1	nan	run 215	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_52_E3_170410224820.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	1	nan	run 216	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	1	nan	run 217	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	1	nan	run 218	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	1	nan	run 219	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_56_E7_170410182751.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	1	nan	run 220	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	1	nan	run 221	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_58_E9_170411161451.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	1	nan	run 222	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_59_E10_170411073057.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	1	nan	run 223	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	1	nan	run 224	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	1	nan	run 225	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	1	nan	run 226	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	1	nan	run 227	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_63_F2_170410161757.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	1	nan	run 228	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	1	nan	run 229	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	1	nan	run 230	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_66_F5_170411094153.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	1	nan	run 231	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	1	nan	run 232	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	1	nan	run 233	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	1	nan	run 234	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_7_A7_170411140356.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	1	nan	run 235	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	1	nan	run 236	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_71_F10_170411150921.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	1	nan	run 237	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_72_F11_170411104724.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	1	nan	run 238	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	1	nan	run 239	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_74_G1_170410115825.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	1	nan	run 240	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_75_G2_170411062533.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	1	nan	run 241	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_76_G3_170411052011.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	1	nan	run 242	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	1	nan	run 243	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_78_G5_170411172027.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	1	nan	run 244	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	1	nan	run 245	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep1_9_A9_170411125828.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	2	nan	run 246	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_1_A1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	2	nan	run 247	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	2	nan	run 248	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	2	nan	run 249	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	2	nan	run 250	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_13_B1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	2	nan	run 251	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_14_B2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	2	nan	run 252	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	2	nan	run 253	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	2	nan	run 254	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_17_B5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	2	nan	run 255	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_18_B6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	2	nan	run 256	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_19_B7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	2	nan	run 257	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_2_A2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	2	nan	run 258	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	2	nan	run 259	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	2	nan	run 260	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	2	nan	run 261	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_23_B11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	2	nan	run 262	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_24_B12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	2	nan	run 263	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	2	nan	run 264	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_26_C2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	2	nan	run 265	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	2	nan	run 266	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	2	nan	run 267	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_3_A3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	2	nan	run 268	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	2	nan	run 269	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_31_C6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	2	nan	run 270	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_32_C7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	2	nan	run 271	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_33_C8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	2	nan	run 272	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	2	nan	run 273	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	2	nan	run 274	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	2	nan	run 275	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_37_C12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	2	nan	run 276	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	2	nan	run 277	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_39_D2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	2	nan	run 278	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	2	nan	run 279	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	nan	not available	62	not available	not available	not available	41	2	nan	run 280	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	2	nan	run 281	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	2	nan	run 282	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	2	nan	run 283	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	2	nan	run 284	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	2	nan	run 285	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_46_D9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	2	nan	run 286	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	2	nan	run 287	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	2	nan	run 288	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_49_D12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	2	nan	run 289	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	2	nan	run 290	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_50_E1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	2	nan	run 291	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	2	nan	run 292	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_52_E3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	2	nan	run 293	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	2	nan	run 294	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	2	nan	run 295	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	2	nan	run 296	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_56_E7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	2	nan	run 297	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	2	nan	run 298	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_58_E9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	2	nan	run 299	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_59_E10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	2	nan	run 300	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	2	nan	run 301	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	2	nan	run 302	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	2	nan	run 303	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	2	nan	run 304	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_63_F2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	2	nan	run 305	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	2	nan	run 306	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	2	nan	run 307	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_66_F5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	2	nan	run 308	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	2	nan	run 309	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	2	nan	run 310	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	2	nan	run 311	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_7_A7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	2	nan	run 312	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	2	nan	run 313	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_71_F10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	2	nan	run 314	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_72_F11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	2	nan	run 315	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	2	nan	run 316	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_74_G1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	2	nan	run 317	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_75_G2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	2	nan	run 318	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_76_G3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	2	nan	run 319	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	2	nan	run 320	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_78_G5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	2	nan	run 321	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	2	nan	run 322	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep2_9_A9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 1	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	1	3	nan	run 323	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_1_A1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 10	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	10	3	nan	run 324	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_10_A10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 11	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	11	3	nan	run 325	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_11_A11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 12	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	12	3	nan	run 326	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_12_A12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 13	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	13	3	nan	run 327	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_13_B1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 14	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	14	3	nan	run 328	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_14_B2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 15	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	15	3	nan	run 329	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_15_B3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 16	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	16	3	nan	run 330	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_16_B4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 17	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	17	3	nan	run 331	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_17_B5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 18	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	18	3	nan	run 332	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_18_B6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 19	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	19	3	nan	run 333	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_19_B7_170418185445.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 2	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	2	3	nan	run 334	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_2_A2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 20	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	20	3	nan	run 335	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_20_B8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 21	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	21	3	nan	run 336	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_21_B9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 22	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	22	3	nan	run 337	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_22_B10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 23	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	23	3	nan	run 338	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_23_B11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 24	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	24	3	nan	run 339	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_24_B12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 25	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	25	3	nan	run 340	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_25_C1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 26	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	26	3	nan	run 341	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_26_C2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 27	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	27	3	nan	run 342	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_27_C3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 28	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	28	3	nan	run 343	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_28_C4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 3	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	3	3	nan	run 344	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_3_A3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 30	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	30	3	nan	run 345	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_30_C5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 31	homo sapiens	plasma	not available	not available	normal	male	not available	73	not available	not available	not available	31	3	nan	run 346	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_31_C6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 32	homo sapiens	plasma	not available	not available	normal	male	not available	49	not available	not available	not available	32	3	nan	run 347	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_32_C7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 33	homo sapiens	plasma	not available	not available	normal	female	not available	66	not available	not available	not available	33	3	nan	run 348	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_33_C8_170420120643.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 34	homo sapiens	plasma	not available	not available	normal	female	not available	61	not available	not available	not available	34	3	nan	run 349	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_34_C9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 35	homo sapiens	plasma	not available	not available	normal	female	not available	44	not available	not available	not available	35	3	nan	run 350	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_35_C10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 36	homo sapiens	plasma	not available	not available	normal	female	not available	64	not available	not available	not available	36	3	nan	run 351	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_36_C11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 37	homo sapiens	plasma	not available	not available	normal	female	not available	48	not available	not available	not available	37	3	nan	run 352	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_37_C12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 38	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	38	3	nan	run 353	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_38_D1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 39	homo sapiens	plasma	not available	not available	normal	male	not available	54	not available	not available	not available	39	3	nan	run 354	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_39_D2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 4	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	4	3	nan	run 355	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_4_A4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 40	homo sapiens	plasma	not available	not available	normal	male	not available	69	not available	not available	not available	40	3	nan	run 356	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_40_D3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 41	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	nan	not available	62	not available	not available	not available	41	3	nan	run 357	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_41_D4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 42	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	74	not available	not available	not available	42	3	nan	run 358	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_42_D5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 43	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	54	not available	not available	not available	43	3	nan	run 359	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_43_D6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 44	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	44	3	nan	run 360	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_44_D7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 45	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	39	not available	not available	not available	45	3	nan	run 361	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_45_D8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 46	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	46	3	nan	run 362	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_46_D9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 47	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	24	not available	not available	not available	47	3	nan	run 363	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_47_D10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 48	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	41	not available	not available	not available	48	3	nan	run 364	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_48_D11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 49	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	62	not available	not available	not available	49	3	nan	run 365	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_49_D12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 5	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	5	3	nan	run 366	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_5_A5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 50	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	57	not available	not available	not available	50	3	nan	run 367	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_50_E1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 51	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	76	not available	not available	not available	51	3	nan	run 368	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_51_E2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 52	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	62	not available	not available	not available	52	3	nan	run 369	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_52_E3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 53	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	66	not available	not available	not available	53	3	nan	run 370	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_53_E4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 54	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	52	not available	not available	not available	54	3	nan	run 371	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_54_E5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 55	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	55	3	nan	run 372	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_55_E6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 56	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	46	not available	not available	not available	56	3	nan	run 373	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_56_E7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 57	homo sapiens	plasma	not available	not available	type II diabetes mellitus	female	not available	55	not available	not available	not available	57	3	nan	run 374	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_57_E8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 58	homo sapiens	plasma	not available	not available	type II diabetes mellitus	male	not available	68	not available	not available	not available	58	3	nan	run 375	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_58_E9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 59	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	68	not available	not available	not available	59	3	nan	run 376	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_59_E10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 6	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	6	3	nan	run 377	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_6_A6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 60	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	71	not available	not available	not available	60	3	nan	run 378	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_60_E11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 61	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	63	not available	not available	not available	61	3	nan	run 379	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_61_E12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 62	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	35	not available	not available	not available	62	3	nan	run 380	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_62_F1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 63	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	63	3	nan	run 381	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_63_F2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 64	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	64	3	nan	run 382	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_64_F3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 65	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	65	not available	not available	not available	65	3	nan	run 383	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_65_F4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 66	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	52	not available	not available	not available	66	3	nan	run 384	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_66_F5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 67	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	female	not available	63	not available	not available	not available	67	3	nan	run 385	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_67_F6.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 68	homo sapiens	plasma	not available	not available	non-alcoholic fatty liver disease	male	not available	53	not available	not available	not available	68	3	nan	run 386	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_68_F7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 69	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	66	not available	not available	not available	69	3	nan	run 387	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_69_F8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 7	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	7	3	nan	run 388	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_7_A7.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 70	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	61	not available	not available	not available	70	3	nan	run 389	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_70_F9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 71	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	66	not available	not available	not available	71	3	nan	run 390	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_71_F10.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 72	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	56	not available	not available	not available	72	3	nan	run 391	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_72_F11.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 73	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	73	3	nan	run 392	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_73_F12.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 74	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	48	not available	not available	not available	74	3	nan	run 393	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_74_G1.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 75	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	57	not available	not available	not available	75	3	nan	run 394	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_75_G2.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 76	homo sapiens	plasma	not available	not available	cirrhosis of liver	male	not available	54	not available	not available	not available	76	3	nan	run 395	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_76_G3.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 77	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	46	not available	not available	not available	77	3	nan	run 396	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_77_G4.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 78	homo sapiens	plasma	not available	not available	cirrhosis of liver	female	not available	56	not available	not available	not available	78	3	nan	run 397	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_78_G5.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 8	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	8	3	nan	run 398	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_8_A8.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
sample 9	homo sapiens	plasma	not available	not available	not available	not available	not available	not available	not available	not available	not available	9	3	nan	run 399	proteomic profiling by mass spectrometry	20170405_QEp2_PhGe_SA_LC12-14_Liver_Rep3_9_A9.raw	AC=MS:1002038;NT=label free sample	not available	1	1	AC=MS:1000484;NT=orbitrap	NT=Q Exactive HF-X;AC=MS:1002877	AC=PRIDE:0000563;NT=Reversed-phase chromatography (RP)	nan	AC=PRIDE:0000590;NT=HCD	25 eV;27.5eV;30eV	NT=Trypsin/P;AC=MS:1001313	NT=Lys-C;AC=MS:1001309	NT=Carbamidomethyl;AC=UNIMOD:4;TA=C;MT=fixed	NT=Oxidation;TA=M;AC=UNIMOD:35;MT=variable	NT=Acetyl;TA=N-term;AC=UNIMOD:1;MT=variable	20 ppm	20 ppm	nan
